| Bioactivity | PKC 20-28,myristoylated (Myristoylated protein kinase C inhibitor 20-28) is a cell-permeable PKC inhibitor that can be used in cancer research[1]. |
| Name | PKC 20-28,myristoylated |
| Sequence | {Myr}-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-NH2 |
| Shortening | {Myr}-FARKGALRQ-NH2 |
| Formula | C60H106N18O11 |
| Molar Mass | 1255.60 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Hayabuchi Y, et al. Angiotensin II activates intermediate-conductance Ca2+ -activated K+ channels in arterial smooth muscle cells. J Mol Cell Cardiol. 2006 Dec;41(6):972-9. |
PKC 20-28,myristoylated
CAS: F: C60H106N18O11 W: 1255.60
PKC 20-28,myristoylated (Myristoylated protein kinase C inhibitor 20-28) is a cell-permeable PKC inhibitor that can be u
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.